...offer from TTAM along with a $10 million termination fee. FierceBiotech One wonders where the egos shake out. Regeneron Pharmaceuticals has sound reasons for acquiring 23andMe’s genomic data to add to its developing genomics research. The price, based on our own estimate of over 10.85 million users left providing consent, was generous on a per-user basis. But you really do have to wonder why Anne Wojcicki cannot let go and say ‘enough’. This Editor, while not a mindreader nor an attorney, believes that the Missouri court may look upon Ms. Wojcicki’s new filing with a severely jaundiced eye. There was... Continue Reading
Search Results for data breach
TTA’s Unofficial Summer kickoff: breaking up UnitedHealth to save it, post-GLP-1 weight gain, soft robots, NZ telehealth controversy, Midi Health widening women’s health, AssistIQ, Ambience, more!
...out the VA/Oracle EHR in ‘waves’, Fuze Health formed from LetsGetChecked/Truepill, hacking and ransomware 92% of PHI data breaches (A renaming of a 2024 ‘arranged marriage’–can it be saved?) News roundup: Hinge Health public @$32/share, lower valuation. Is WeightWatchers game over? Calibrate replaces CEO, new prez for Oak Street, NMC gets ‘Smarter’ rolling up 3 portfolio companies, another splash of investor ‘cold water’ (The first health tech IPO in 2 years and ‘smushing’ when they can’t) Update: Masimo’s website status and an analysis of the Sound United sale (Getting up and running post-attack, but what happened?) 23andMe sold to Regeneron... Continue Reading
News roundup: GLP-1 weight regain real, soft robots walk off 3D printer, Ambience’s AI coding beats doctors by 27%, Get a Second Opinion debuts, $11.5M for AssistIQ
...interactions, alternatives, and cost. Its two tools are: Discovery Tool: Analyzes a single medication and/or condition against a unique profile, generating a comprehensive report with rankings, supporting data, and average monthly cost—often identifying more effective alternatives with fewer side effects at a lower cost. The annual plan covers up to 10 reports. Planner: Evaluates up to 10 medications treating up to 10 conditions simultaneously, identifying optimal treatment combinations while minimizing side effects and adverse interactions. The annual plan covers up to two reports. The profile is built using their AI Diagnostician engine, which analyzes age, sex, BMI, medications, pre-existing conditions,... Continue Reading
Job Posting: Yosi Health seeks Demand Generation Manager and Manager, Data Analytics & Reporting
...meetings to study the situation and explores out-of-box ideas, then you may be the person to lead Yosi Health’s demand generation efforts. For more details and to apply, see their Careers section and the job listing here. Manager, Data Analytics & Reporting This position oversees data collection, analysis, reporting and infrastructure maintenance to help gain valuable insights to make business decisions. It is a full-time position, hybrid and based in their NYC office. About the Role – Is this You? As Manager of Data Analytics & Reporting, you will play a central role in shaping Yosi Health’s data strategy —... Continue Reading
Should free-falling UnitedHealth Group be broken up? Or break itself up to survive, before it becomes another GE? (updated)
...now is the US’ fourth-largest firm by revenues, just behind Walmart, Amazon, and Apple. (Visual Capitalist 17 Dec 2024, based on American Medical Association data). Their growth has been led by acquisition into Optum, their health services division. It houses their owned physician practices as the largest owner of practices in the US with 90,000 physicians, their ACO relationships, data analytics, Change Healthcare, the largest billing and claims management company, home care/hospice, the third largest PBM Optum Rx, a venture investment arm, and much more. Optum is the massive symbol of the integration envisioned by former and current CEO Stephen... Continue Reading
TTA’s Blooming Spring 5: Hinge Health’s IPO, 23andMe bought by Regeneron, sans Lemonaid, WeightWatchers’ future, debuts of Smarter Technologies and Fuze Health, VA EHR update, more!
...Monday newsletter will be on Tuesday. News roundup 22 May: an inflight ‘save’ and AliveCor’s KardiaMobile, rolling out the VA/Oracle EHR in ‘waves’, Fuze Health formed from LetsGetChecked/Truepill, hacking and ransomware 92% of PHI data breaches (A renaming of a 2024 ‘arranged marriage’–can it be saved?) News roundup: Hinge Health public @$32/share, lower valuation. Is WeightWatchers game over? Calibrate replaces CEO, new prez for Oak Street, NMC gets ‘Smarter’ rolling up 3 portfolio companies, another splash of investor ‘cold water’ (The first health tech IPO in 2 years and ‘smushing’ when they can’t) Update: Masimo’s website status and an analysis... Continue Reading
News roundup 22 May: an inflight ‘save’ and AliveCor’s KardiaMobile, rolling out the VA/Oracle EHR in ‘waves’, Fuze Health formed from LetsGetChecked/Truepill, hacking and ransomware 92% of PHI data breaches
...the more common causes were insider theft, unauthorized access/disclosure, and improper disposal or loss. They have nearly vanished as the ‘business of breaches’ has settled down and internal security has approved. A cross-sectional study published as a research letter in JAMA Network surveyed breaches from 2009 to 2024 using HHS’s Office of Civil Rights (HHS-OCR) reporting. Of 566 incidents in 2024, 457 were “IT incidents” and 61 were tagged as ransomware, totaling 92%. Despite the massive Change Healthcare breach, ransomware breaches fell to 11%. Considering patient records, there were 170 million breached in 2024 and hacking/IT incidents accounted for 91%... Continue Reading
Update: Masimo’s website status and an analysis of the Sound United sale
...and manufacturing systems. This Editor will be waiting to see if the new Masimo will be transparent with customers, investors, and the press as to what happened, the remediation of their systems, and securing their IT. Customers will need reassurance that their continuous monitoring and patient-worn monitoring devices are secure. Moreover, Health and Human Services’ Office of Civil Rights (HHS-OCR) requires reports of data breaches affecting or potentially affecting protected health information (PHI). I will also be waiting to see if their consumer health wearables bounce back and go back on sale (they are currently unavailable)–after winning their fights with... Continue Reading
23andMe sold to Regeneron for $256M in court-supervised bankruptcy, sans Lemonaid. And is it worth it? (Updated 27 May for delisting)
...to have their data used for research–12.75 million. (We will leave aside the question that this was ‘meaningful consent’, as the Electronic Privacy Information Center termed it in Recorded Future News.) Let’s assume that 15% took the advice of their attorneys general and deleted (or will delete) their data, or that data is somehow compromised. Subtract 1.9 million. That is data on 10.85 million users–not counting the unknown amount of deidentified survey information from the data deleters that may or may not be accessible. Regeneron is acquiring genetic data and some research at $23.60 per user. That raw number does... Continue Reading
TTA’s Blooming Spring 4: UnitedHealth’s CEO change doesn’t stop market pummeling, Omada’s IPO, Theranos redux, Holmes loses appeal, Synchron BCI and Apple, exec security cost, raises, more!
...management startup, Parkinson’s data, two good raises, and what payers pay to keep their execs safe. Short takes: Synchron BCI integrates with Apple devices, Shields Health partners with Duke on specialty pharmacy, raises for Cohere Health, Olio (More BCI action with Apple getting into it) Theranos’ revenge? Holmes’ partner Billy Evans founds a startup for diagnostic testing, denies it is ‘Theranos 2.0’; Holmes loses Federal rehearing appeal. (Is Holmes advising long distance? Letters from a Texas Jail?) News roundup: Omada Health files for IPO, UPMC-Redesign partner on chronic pain management, OK and PA AGs warn 23andMe users to delete data,... Continue Reading
Most Recent Comments